DYRK1B and metabolic syndrome: Recent studies have revealed that mutations in DYRK1B linked to metabolic syndrome impair the chaperone-mediated maturation of its kinase domain, thereby disrupting its regulatory role in metabolic pathways (Abu Jhaisha et al., 2017).